Side-by-side comparison of AI visibility scores, market position, and capabilities
McKinney TX direct-to-consumer life insurance (NYSE: GL) at $5.78B 2024 revenue (+6%); net income $1.07B (+10%), American Income Life union distribution, middle-income families competing with Aflac and Lincoln Benefit.
Globe Life Inc. is a McKinney, Texas-based life and supplemental health insurance holding company — publicly traded on the New York Stock Exchange (NYSE: GL) as an S&P 500 Financials component — distributing direct-to-consumer and agent-sold life insurance, supplemental health insurance, and accident coverage to middle-income American families across all 50 states through five operating divisions: American Income Life (labor union and affinity group market), Liberty National Life Division (home service and agency market), Globe Life Direct Response Division (direct mail and internet), Family Heritage Life (supplemental health), and United American Insurance (individual health), through approximately 8,000 employees and 10,000+ agents. In fiscal year 2024, Globe Life reported annual revenue of $5.78 billion (+6.07%), net income of $1.07 billion (+10%), and net income per diluted share of $11.94 (versus $10.07 in 2023), demonstrating consistent profitability improvement. The company (formerly known as Torchmark Corporation until its 2019 rebrand) has served financially underserved American families for over 70 years, offering face amounts from $5,000 to $100,000 in whole life and term life policies — a segment of the life insurance market where major carriers (MetLife, Prudential, New York Life) compete less aggressively because smaller face amounts generate lower individual premium revenue. CEO Matt Darden leads Globe Life's network of five distribution channels that reach different segments of the middle-income insurance market.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.